IMEXHS has won a public tender in Mexico to deploy its Aquila+ AI-integrated radiology platform across 20 hospitals and clinics. The deal is projected to generate $384,000 in new Annual Recurring Revenue and includes a one-time implementation fee of $50,000, with completion expected by end-June 2026.
Company Information
Company
IMEXHS
Location
Mexico
About
IMEXHS is a technology company focused on developing advanced solutions for the healthcare industry. Their flagship product, the Aquila+ platform, integrates AI to streamline radiology workflows. The company has been on a trajectory of profitability and growth, increasing revenue and optimizing its balance sheet. IMEXHS aims to improve patient outcomes through innovation in medical technology.